Drug	Gene	Observed_logFC	Civic_Variant	Tier	Evidence_type	ct	Disease	Evidence
ANTI-ERBB3 MONOCLONAL ANTIBODY AV-203	ERBB3	1.07185435551187	EXPRESSION	tier_1	PREDICTIVE	nct	CANCER	{'DOES_NOT_SUPPORT:SENSITIVITYRESPONSE': {'D': ['PUBMED_25542901:ACCEPTED:ACCEPTED:NA:3']}}
9F7-F11+PERTUZUMAB	ERBB3	1.07185435551187	EXPRESSION	tier_1	PREDICTIVE	nct	PANCREATIC DUCTAL ADENOCARCINOMA	{'SUPPORTS:SENSITIVITYRESPONSE': {'D': ['PUBMED_25216528:ACCEPTED:ACCEPTED:NA:3']}}
CETUXIMAB	ERBB3	1.07185435551187	OVEREXPRESSION	tier_1	PREDICTIVE	nct	COLORECTAL CANCER	{'SUPPORTS:RESISTANCE': {'B': ['PUBMED_25520391:ACCEPTED:ACCEPTED:NA:4']}}
TRASTUZUMAB EMTANSINE	ERBB3	1.07185435551187	OVEREXPRESSION	tier_1	PREDICTIVE	nct	HER2-RECEPTOR POSITIVE BREAST CANCER	{'DOES_NOT_SUPPORT:RESISTANCE': {'B': ['PUBMED_26920887:ACCEPTED:ACCEPTED:NA:2']}}
GEFITINIB	ERBB3	1.07185435551187	OVEREXPRESSION	tier_1	PREDICTIVE	nct	CANCER	{'SUPPORTS:RESISTANCE': {'D': ['PUBMED_24685132:ACCEPTED:ACCEPTED:NA:4']}}
HER2 INHIBITOR CP-724,714	ERBB3	1.07185435551187	OVEREXPRESSION	tier_1	PREDICTIVE	nct	CANCER	{'SUPPORTS:RESISTANCE': {'D': ['PUBMED_24685132:ACCEPTED:ACCEPTED:NA:4']}}
SELUMETINIB	ERBB3	1.07185435551187	OVEREXPRESSION	tier_1	PREDICTIVE	nct	CANCER	{'SUPPORTS:RESISTANCE': {'D': ['PUBMED_24685132:ACCEPTED:ACCEPTED:NA:4']}}
AFATINIB+SELUMETINIB	ERBB3	1.07185435551187	OVEREXPRESSION	tier_1	PREDICTIVE	nct	CANCER	{'SUPPORTS:SENSITIVITYRESPONSE': {'D': ['PUBMED_24685132:ACCEPTED:ACCEPTED:NA:3']}}
